NQMC Update Service: May 26, 2014 ▲ Physician Consortium for Performance Improvement®

NQMC Update Service: May 26, 2014

Physician Consortium for Performance Improvement®

• Atrial fibrillation (AF) and atrial flutter: percentage of calendar months during the reporting period during which patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter, receiving warfarin therapy, have at least one INR measurement made. This updates a previously published measure summary.

• Atrial fibrillation (AF) and atrial flutter: percentage of patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter in whom assessment of all of the specified thromboembolic risk factors using the CHADS₂ risk criteria is documented. This updates a previously published measure summary.

• Atrial fibrillation (AF) and atrial flutter: percentage of patients aged 18 years and older with a diagnosis of nonvalvular AF or atrial flutter whose assessment of the specified thromboembolism risk factors indicate one or more high-risk factors or more than one moderate risk factor, as determined by CHADS₂ risk stratification, who are prescribed warfarin OR another oral anticoagulant drug that is FDA approved for the prevention of thromboembolism. This updates a previously published measure summary.